Novavax (NVAX) Reports Positive Phase 1 Data for COVID-19 Vaccine Candidate
Go back to Novavax (NVAX) Reports Positive Phase 1 Data for COVID-19 Vaccine Candidate| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.15 +0.15 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.00 | 52 Week High | $9.23 | |||
| Open | $8.81 | 52 Week Low | $1.16 | |||
| Day High | $9.59 | P/E | N/A | |||
| Day Low | $8.81 | EPS | $-0.30 | |||
| Volume | 3,251,956 | |||||
